GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » Cyclically Adjusted Price-to-FCF

Forward Pharma A/S (Forward Pharma A/S) Cyclically Adjusted Price-to-FCF : 0.56 (As of Jun. 04, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S Cyclically Adjusted Price-to-FCF?

As of today (2024-06-04), Forward Pharma A/S's current share price is $400.50. Forward Pharma A/S's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec21 was $710.20. Forward Pharma A/S's Cyclically Adjusted Price-to-FCF for today is 0.56.

The historical rank and industry rank for Forward Pharma A/S's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FWPAY' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.8
Current: 0.56

During the past 11 years, Forward Pharma A/S's highest Cyclically Adjusted Price-to-FCF was 0.80. The lowest was 0.00. And the median was 0.00.

FWPAY's Cyclically Adjusted Price-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 49.34 vs FWPAY: 0.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Forward Pharma A/S's adjusted free cash flow per share data of for the fiscal year that ended in Dec21 was $-98.292. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $710.20 for the trailing ten years ended in Dec21.

Shiller PE for Stocks: The True Measure of Stock Valuation


Forward Pharma A/S Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Forward Pharma A/S's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forward Pharma A/S Cyclically Adjusted Price-to-FCF Chart

Forward Pharma A/S Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.59 2.40

Forward Pharma A/S Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.59 - 2.40 -

Competitive Comparison of Forward Pharma A/S's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Forward Pharma A/S's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forward Pharma A/S's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forward Pharma A/S's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Forward Pharma A/S's Cyclically Adjusted Price-to-FCF falls into.



Forward Pharma A/S Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Forward Pharma A/S's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=400.50/710.2
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forward Pharma A/S's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec21 is calculated as:

For example, Forward Pharma A/S's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec21 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec21 (Change)*Current CPI (Dec21)
=-98.292/106.6000*106.6000
=-98.292

Current CPI (Dec21) = 106.6000.

Forward Pharma A/S Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201212 -152.130 98.300 -164.975
201312 -364.043 99.000 -391.990
201412 -556.824 99.400 -597.157
201512 -264.993 99.800 -283.049
201612 -252.859 100.300 -268.741
201712 9,399.440 101.300 9,891.217
201812 -616.125 102.100 -643.280
201912 -92.958 102.900 -96.301
202012 -238.042 103.400 -245.409
202112 -98.292 106.600 -98.292

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Forward Pharma A/S  (OTCPK:FWPAY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Forward Pharma A/S Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Forward Pharma A/S's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Forward Pharma A/S (Forward Pharma A/S) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100
Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.